En

EFMC Awards

EFMC Awards 2022 - Call for Nominations

To acknowledge outstanding achievements in the field of Medicinal Chemistry and Chemical Biology, EFMC confers three awards every two years. The 2022 Awards will be presented at the XXVII EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2022) to be held in Nice, France on September 4-8, 2022.

All 3 awards consist of a diploma, € 7.500 and an invitation to give a headline presentation at EFMC-ISMC 2022.

Nominations for these Awards consist of a nomination letter, a brief CV including a list of selected publications and two supporting letters. Self-nominations are also accepted. The nominations should be submitted to Prof. Rui Moreira, President of the EFMC, via the following link:

Deadline for submission: January 31, 2022

The Award will be given for outstanding achievements in scientific research, together with a contribution to the development of international organisational structures in Medicinal Chemistry and Chemical Biology.

To acknowledge and recognise outstanding research in the field of Medicinal Chemistry in its broadest sense by a young scientist. This Award has been established with the support of UCB Pharma.

To encourage innovation and investigation in technological development related to drug discovery, this Award established with the support of Prous Institute will be given for the discovery, evaluation or use of new technologies.

EFMC Awards 2020 - Ceremony

The 2020 Award Ceremony took place during the XXVI EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2021), held on August 29-September 2, 2021 in an hybrid format: virtually and from the Novartis Campus in Basel, Switzerland. 

  • Nauta Pharmacochemistry Award for Medicinal Chemistry and Chemical Biology

Prof. Adriaan Ijzerman (Leiden University, The Netherlands) received his award from both Dr Yves P. Auberson (EFMC President in 2020) and Prof. Henk Timmerman (W. Th. Nauta Foundation for Pharmacochemistry), before delivering a lecture entitled Partial Agonism in the Picture

  • UCB-Ehrlich Award for Excellence in Medicinal Chemistry

Dr Malin Lemurell (AstraZeneca, Sweden) virtually received his award from both Dr Yves P. Auberson (EFMC President in 2020) and Dr Adrian Hall (UCB), before delivering a lecture entitled Experiences & Future Direction for Medicinal Chemistry in Cardiovascular, Renal and Metabolism Diseases

  • Prous Institute - Overton and Meyer Award for New technologies in Drug Discovery

Prof. Gisbert Schneider (ETH Zürich, Switzerland) received his award from both Dr Yves P. Auberson (EFMC President in 2020) and Dr Josep Jr. Prous (Prous Institue), before delivering a lecture entitled De Novo Drug Design with Machine Intelligence.

Previous Laureates

Nauta Pharmacochemistry Award for Medicinal Chemistry and Chemical Biology

  • 2018: Prof. Christa Müller, University of Bonn, Germany
  • 2016: Prof. François Diederich, ETH Zürich, Switzerland
  • 2014: Dr Paul Leeson, GlaxoSmithKline, United Kingdom
  • 2012: Prof. Alexander Levitzki, THe Hebrew University of Jerusalem, Israel
  • 2010: Prof. Camille George Wermuth, University Louis Pasteur Strasbourg and Prestwick Chemicals

UCB-Ehrlich Award for Excellence in Medicinal Chemistry

  • 2018: Prof. Adam Nelson, University of Leeds, United Kingdom
  • 2016: Prof. Paul J. Hergenrother, University of Illinois at Urbana-Champaign, USA
  • 2014: Prof. Craig Crews, Yale University, Department of Chemistry, New Haven, USA
  • 2012: Dr Krzysztof Józwiak, Department of Chemistry, Medical University of Lublin, Poland
  • 2010: Dr Anthony Wood, Pfizer Global Research and Development, United Kingdom

Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery

  • 2018: Prof. Benjamin Cravatt – Scripps Research Institute, USA
  • 2016: Prof. Jan Steyaert, VIB & VU Brussels, Belgium
  • 2014: Prof. György Ferenczy and Prof. György Keseru, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary
  • 2012: Dr Harren Jhoti, Astex Pharmaceuticals, UK
  • 2010: Prof. Klaus Müller, ETH Zürich, Switzerland